التفاصيل البيبلوغرافية
| العنوان: |
Risk prediction of hepatocellular carcinoma in patients with cirrhosis: The ADRESS-HCC risk model. |
| المؤلفون: |
Flemming, Jennifer A., Yang, Ju Dong, Vittinghoff, Eric, Kim, W. Ray, Terrault, Norah A. |
| المصدر: |
Cancer (0008543X); Nov2014, Vol. 120 Issue 22, p3485-3493, 9p |
| مصطلحات موضوعية: |
CANCER risk factors, LIVER cancer, CIRRHOSIS of the liver, ETIOLOGY of diseases, DIABETES, SEVERITY of illness index, AGE factors in disease, PATIENTS |
| مستخلص: |
BACKGROUND All patients with cirrhosis are at risk of developing hepatocellular carcinoma (HCC). This risk is not uniform because other patient-related factors influence the risk of HCC. The objective of the current study was to develop an HCC risk prediction model to estimate the 1-year probability of HCC to assist with patient counseling. METHODS Between 2002 and 2011, a cohort of 34,932 patients with cirrhosis was identified from a national liver transplantation waitlist database from the United States. Cox proportional hazards regression methods were used to develop and validate a risk prediction model for incident HCC. In the validation cohort, discrimination and calibration of the model was examined. External validation was conducted using patients with cirrhosis who were enrolled in the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) study. RESULTS HCC developed in 1960 patients (5.6%) during a median follow-up of 1.3 years (interquartile range, 0.47 years-2.83 years). Six baseline clinical variables, including age, diabetes, race, etiology of cirrhosis, sex, and severity (ADRESS) of liver dysfunction were independently associated with HCC and were used to develop the ADRESS-HCC risk model. C-indices in the derivation and internal validation cohorts were 0.704 and 0.691, respectively. In the validation cohort, the predicted cumulative incidence of HCC by the ADRESS-HCC model closely matched the observed data. In patients with cirrhosis in the HALT-C cohort, the model stratified patients correctly according to the risk of developing HCC within 5 years. CONCLUSIONS The ADRESS-HCC risk model is a useful tool for predicting the 1-year risk of HCC among patients with cirrhosis. Cancer 2014;120:3485-3493. © 2014 American Cancer Society. [ABSTRACT FROM AUTHOR] |
|
Copyright of Cancer (0008543X) is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder